1. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 6 (June 2016) Authors: Vansteenkiste, Johan F; Cho, Byoung Chul; Vanakesa, Tonu; De Pas, Tommaso; Zielinski, Marcin; Kim, Moon Soo; Jassem, Jacek; Yoshimura, Masahiro; Dahabreh, Jubrail; Nakayama, Haruhiku; Havel, Libor; Kondo, Haruhiko; Mitsudomi, Tetsuya; Zarogoulidis, Konstantinos; Gladkov, Oleg A; Udud, Katalin; Ta... Journal: Lancet oncology Issue: Volume 17:Issue 6(2016:Jun.) Page Start: 822 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Issue 3 (March 2017) Authors: Seymour, Lesley; Bogaerts, Jan; Perrone, Andrea; Ford, Robert; Schwartz, Lawrence H; Mandrekar, Sumithra; Lin, Nancy U; Litière, Saskia; Dancey, Janet; Chen, Alice; Hodi, F Stephen; Therasse, Patrick; Hoekstra, Otto S; Shankar, Lalitha K; Wolchok, Jedd D; Ballinger, Marcus; Caramella, Caroline; d... Journal: Lancet oncology Issue: Volume 18:Issue 3(2017:Mar.) Page Start: e143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2018) Authors: Dreno, Brigitte; Thompson, John F; Smithers, Bernard Mark; Santinami, Mario; Jouary, Thomas; Gutzmer, Ralf; Levchenko, Evgeny; Rutkowski, Piotr; Grob, Jean-Jacques; Korovin, Sergii; Drucis, Kamil; Grange, Florent; Machet, Laurent; Hersey, Peter; Krajsova, Ivana; Testori, Alessandro; Conry, Robert... Journal: Lancet oncology Issue: Volume 19:Issue 7(2018) Page Start: 916 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. RECIST 1.1 – Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group. (July 2016) Authors: Schwartz, Lawrence H.; Seymour, Lesley; Litière, Saskia; Ford, Robert; Gwyther, Stephen; Mandrekar, Sumithra; Shankar, Lalitha; Bogaerts, Jan; Chen, Alice; Dancey, Janet; Hayes, Wendy; Hodi, F. Stephen; Hoekstra, Otto S.; Huang, Erich P.; Lin, Nancy; Liu, Yan; Therasse, Patrick; Wolchok, Jedd D.;... Journal: European journal of cancer Issue: Volume 62(2016) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. RECIST 1.1—Update and clarification: From the RECIST committee. (July 2016) Authors: Schwartz, Lawrence H.; Litière, Saskia; de Vries, Elisabeth; Ford, Robert; Gwyther, Stephen; Mandrekar, Sumithra; Shankar, Lalitha; Bogaerts, Jan; Chen, Alice; Dancey, Janet; Hayes, Wendy; Hodi, F. Stephen; Hoekstra, Otto S.; Huang, Erich P.; Lin, Nancy; Liu, Yan; Therasse, Patrick; Wolchok, Jedd... Journal: European journal of cancer Issue: Volume 62(2016) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Servier's pipeline in oncology: moving from research to patients. (March 2016) Authors: Therasse, Patrick; Abastado, Jean-Pierre Journal: Future oncology Issue: Volume 12:Number 5(2016) Page Start: 589 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The Servier oncology pipeline in 2017. (July 2017) Authors: Therasse, Patrick; Perron, Beatrice; Novack, Sarah A; Abastado, Jean-Pierre Journal: Future oncology Issue: Volume 13:Number 17(2017) Page Start: 1527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗